These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
923 related items for PubMed ID: 30657555
1. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma. Cheng B, Ding F, Huang CY, Xiao H, Fei FY, Li J. Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555 [Abstract] [Full Text] [Related]
2. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma. Xia YH, Ren L, Li JZ, Gao F. Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539 [Abstract] [Full Text] [Related]
3. Long Noncoding RNA HOTAIR Contributes to Progression in Hepatocellular Carcinoma by Sponging miR-217-5p. Gong X, Zhu Z. Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535 [Abstract] [Full Text] [Related]
4. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. Wang H, Ke J, Guo Q, Barnabo Nampoukime KP, Yang P, Ma K. J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921 [Abstract] [Full Text] [Related]
5. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma. Duan X, Li W, Hu P, Jiang B, Yang J, Zhou L, Mao X, Tian B. Biosci Rep; 2020 Oct 30; 40(10):. PubMed ID: 33078826 [Abstract] [Full Text] [Related]
6. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma. Wei GY, Hu M, Zhao L, Guo WS. Eur Rev Med Pharmacol Sci; 2019 Jun 30; 23(12):5158-5167. PubMed ID: 31298411 [Abstract] [Full Text] [Related]
7. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y, He X. Yonsei Med J; 2019 Mar 30; 60(3):267-276. PubMed ID: 30799589 [Abstract] [Full Text] [Related]
8. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis. Li ML, Zhang Y, Ma LT. Eur Rev Med Pharmacol Sci; 2019 Dec 30; 23(24):10708-10720. PubMed ID: 31858580 [Abstract] [Full Text] [Related]
9. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1. Jiang SP, Li ZR. Eur Rev Med Pharmacol Sci; 2019 Mar 30; 23(5):2028-2037. PubMed ID: 30915746 [Abstract] [Full Text] [Related]
10. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase. Fei X, Zhang P, Pan Y, Liu Y. Yonsei Med J; 2020 Jun 30; 61(6):460-470. PubMed ID: 32469170 [Abstract] [Full Text] [Related]
11. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Shi Y, Yan F, Wang F, Pan L. Tissue Cell; 2021 Oct 30; 72():101534. PubMed ID: 33991762 [Abstract] [Full Text] [Related]
12. miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2. Li H, Guo D, Zhang Y, Yang S, Zhang R. Cancer Biother Radiopharm; 2020 Oct 30; 35(8):605-614. PubMed ID: 31967930 [Abstract] [Full Text] [Related]
13. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z, Xia X, Lu J. Med Sci Monit; 2020 Jan 19; 26():e919241. PubMed ID: 31955177 [Abstract] [Full Text] [Related]
14. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma. Yan TH, Qiu C, Sun J, Li WH. Eur Rev Med Pharmacol Sci; 2018 May 19; 22(10):3038-3046. PubMed ID: 29863248 [Abstract] [Full Text] [Related]
15. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3. Li Z, Wu L, Tan W, Zhang K, Lin Q, Zhu J, Tu C, Lv X, Jiang C. Ann Hepatol; 2021 May 19; 23():100345. PubMed ID: 33812045 [Abstract] [Full Text] [Related]
16. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma. Liang Z, Li X, Duan F, Song L, Wang Z, Li X, Yang P, Li L. Hum Cell; 2022 Jan 19; 35(1):299-309. PubMed ID: 34784010 [Abstract] [Full Text] [Related]
17. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression. Qian X, Wang Y, Hu W, Xu X, Gao L, Meng Y, Yan J. Tissue Cell; 2022 Feb 19; 74():101721. PubMed ID: 34979376 [Abstract] [Full Text] [Related]
18. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Ding Z, Guo L, Deng Z, Li P. Ann Hepatol; 2020 Feb 19; 19(3):269-279. PubMed ID: 32089501 [Abstract] [Full Text] [Related]
19. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2. Qiu G, Lin Y, Zhang H, Wu D. Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123 [Abstract] [Full Text] [Related]
20. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Wang JT, Wang ZH. Eur Rev Med Pharmacol Sci; 2018 Nov 31; 22(21):7233-7239. PubMed ID: 30468466 [Abstract] [Full Text] [Related] Page: [Next] [New Search]